These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36109189)

  • 1. Validity of Danish public criteria for providing flash glucose monitoring to participants with type 1 diabetes-An explorative cohort study.
    Nielsen IR; Priergaard MK; Kofoed-Enevoldsen A
    Endocrinol Diabetes Metab; 2022 Nov; 5(6):e366. PubMed ID: 36109189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
    Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
    BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study.
    Tumminia A; Milluzzo A; Festa C; Fresa R; Pintaudi B; Scavini M; Vitacolonna E; Napoli A; Sciacca L
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1851-1859. PubMed ID: 33975741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.
    Halbron M; Bourron O; Andreelli F; Ciangura C; Jacqueminet S; Popelier M; Bosquet F; Rouanet S; Amouyal C; Hartemann A
    Diabetes Technol Ther; 2019 Jul; 21(7):409-412. PubMed ID: 31265349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Outcomes of Glucose Sensor Use in Type 1 Diabetes-Findings from a Large UK Centre.
    Lee K; Gunasinghe S; Chapman A; Findlow LA; Hyland J; Ohol S; Urwin A; Rutter MK; Schofield J; Thabit H; Leelarathna L
    Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of average change in laboratory-measured HbA1c among people with type 1 diabetes mellitus using the 14 day Flash Glucose Monitoring System.
    Gordon I; Rutherford C; Makarounas-Kirchmann K; Kirchmann M
    Diabetes Res Clin Pract; 2020 Jun; 164():108158. PubMed ID: 32333970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
    Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of flash glucose monitoring on glycemic control varies with the age and residual β-cell function of patients with type 1 diabetes mellitus.
    Zhang L; Xu Y; Jiang X; Wu J; Liu F; Fan L; Li X; Yin G; Yang L
    J Diabetes Investig; 2022 Mar; 13(3):552-559. PubMed ID: 34637185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4).
    Fokkert M; van Dijk P; Edens M; Barents E; Mollema J; Slingerland R; Gans R; Bilo H
    BMJ Open Diabetes Res Care; 2019; 7(1):e000809. PubMed ID: 31875133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved HbA1c and reduced glycaemic variability after 1-year intermittent use of flash glucose monitoring.
    Zhang W; Liu Y; Sun B; Shen Y; Li M; Peng L; Duan H; Su X; Lu S; Tian X; Tian Y
    Sci Rep; 2021 Dec; 11(1):23950. PubMed ID: 34907285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of metabolic control and use of flash glucose monitoring systems in a cohort of pediatric, adolescents, and adults patients with Type 1 diabetes.
    Bahíllo-Curieses MP; Díaz-Soto G; Vidueira-Martínez AM; Torres-Ballester I; Gómez-Hoyos E; de Luis-Román D
    Endocrine; 2021 Jul; 73(1):47-51. PubMed ID: 33754313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
    Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5).
    Lameijer A; Fokkert MJ; Edens MA; Slingerland RJ; Bilo HJG; van Dijk PR
    J Clin Transl Endocrinol; 2020 Dec; 22():100237. PubMed ID: 33102135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes.
    Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I
    Endocr J; 2020 Oct; 67(10):1055-1062. PubMed ID: 32565500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
    Ajjan RA; Jackson N; Thomson SA
    Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme.
    Yeoh E; Png D; Koh PL; Sum CF; Lim SC; Tan HH; Ubeynarayana CU; Subramaniam T
    Diabet Med; 2022 Jan; 39(1):e14733. PubMed ID: 34698420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring-derived glycemic makers in children and adolescents with type 1 diabetes.
    Suzuki J; Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Morioka I
    Pediatr Int; 2021 Feb; 63(2):154-159. PubMed ID: 32744360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial.
    Zhou Y; Deng H; Liu H; Yang D; Xu W; Yao B; Yan J; Weng J
    BMJ Open; 2020 Dec; 10(12):e039400. PubMed ID: 33277281
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.